PHMMF vs REGN: Which Stock is Better?

Side-by-side comparison of Pharma Mar SAU and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

PHMMF

Pharma Mar SAU

$106.48

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricPHMMFREGNWinner
Market Cap$1.68B$78.87BREGN
P/E Ratio18.3417.98REGN
EPS (TTM)$5.07$41.48REGN
Revenue Growth0.9%0.0%PHMMF
Gross Margin94.5%44.6%PHMMF

Analyze PHMMF

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PHMMF or REGN a better investment?

Comparing PHMMF and REGN: Pharma Mar SAU has a market cap of $1.68B while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PHMMF and REGN?

PHMMF (Pharma Mar SAU) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PHMMF or REGN?

Based on P/E ratios, REGN trades at a lower multiple (18.0x vs 18.3x).

Which is growing faster: PHMMF or REGN?

PHMMF has higher revenue growth at 0.9% vs 0.0% for REGN.

Which company is more profitable: PHMMF or REGN?

Pharma Mar SAU (PHMMF) has higher gross margins at 94.5% compared to 44.6% for REGN.

Which is the larger company: PHMMF or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $1.68B for PHMMF.

Should I buy PHMMF or REGN in 2026?

Both PHMMF and REGN have investment merit. PHMMF trades at $106.48 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PHMMF and REGN stock?

Key differences: Market Cap ($1.68B vs $78.87B), P/E Ratio (18.3x vs 18.0x), Revenue Growth (0.9% vs 0.0%), Gross Margin (94.5% vs 44.6%).

Popular Stock Comparisons